Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Tumor infiltrating neutrophil might play a major role in predicting the clinical outcome of breast cancer patients treated with neoadjuvant chemotherapy

Fig. 1

Receiver operating characteristic (ROC) curves of TIN before NACT for chemotherapy efficiency (a), TIN after NACT for ineffectiveness of chemotherapy efficiency (b) and the difference of TIN before and after NACT for chemotherapy efficiency (c). The area under the ROC curve was 0.449 (95% confidence interval [CI], 0.275–0.622, P = 0.473), 0.643 (95% confidence interval [CI], 0.509–0.776, P = 0.019), 0.770 (95% confidence interval [CI], 0.657–0.883, P < 0.001), respectively

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us